Edition:
United Kingdom

Aridis Pharmaceuticals Inc (ARDS.OQ)

ARDS.OQ on NASDAQ Stock Exchange Capital Market

12.65USD
22 Oct 2018
Change (% chg)

$0.03 (+0.24%)
Prev Close
$12.62
Open
$12.65
Day's High
$12.65
Day's Low
$12.65
Volume
739
Avg. Vol
--
52-wk High
$13.85
52-wk Low
$11.91

Latest Key Developments (Source: Significant Developments)

Aridis Pharmaceuticals And Hepalink Entered Amendment To JV Agreement
Thursday, 30 Aug 2018 

Aug 30 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd <002399.SZ>::ARIDIS PHARMACEUTICALS - ON AUG 24, CO AND HEPALINK ENTERED AMENDMENT TO JV AGREEMENT .ARIDIS PHARMACEUTICALS-PURSUANT TO AMENDMENT, CO TO GRANT AR-105 PRODUCT CANDIDATE LICENSE TO SABC, HEPALINK TO CONTRIBUTE ADDITIONAL $1.2 MILLION TO SABC.ARIDIS PHARMACEUTICALS - PURSUANT TO JV AGREEMENT AND AMENDMENT, HEPALINK IS OBLIGATED TO CONTRIBUTE EQUIVALENT OF $7.2 MILLION TO SABC.  Full Article

Aridis' shares rise in muted market debut

Biotechnology company Aridis Pharmaceuticals Inc rose as much as 5.4 percent to $13.70 in its U.S. market debut on Tuesday, joining a host of other small-cap biotechs that have gone public this year.